The ResMarkerDB is provided to advance the knowledge on biomarkers of response to antibody therapy in colorectal and breast cancer, and is intended to be used for research and education.
Database License
The ResMarkerDB database is made available under the Attribution-NonCommercial-ShareAlike 4.0 International License whose text can be found here. If ResMarkerDB is incorporated into other works, we ask that ResMarkerDB is properly cited (see "How do I cite ResMarkerDB?")
ResMarkerDB is developed by the Integrative Biomedical Informatics group, from the Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Research Institute (IMIM), and Pompeu Fabra University (UPF).
FUNDING: We received support from ISCIII-FEDER (PIE15/00008, CP10/00524, CPII16/00026), the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I+D+i 2013-2016, funded by ISCIII and FEDER. The DCEXS is a “Unidad de Excelencia María de Maeztu”, funded by the MINECO (ref: MDM-2014-0370).